These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7870934)

  • 41. Discriminative stimulus effects of apomorphine and 7-OH-DPAT: a potential role for dopamine D3 receptors.
    Sanger DJ; Depoortere R; Perrault G
    Psychopharmacology (Berl); 1997 Apr; 130(4):387-95. PubMed ID: 9160856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
    Weathersby RT; Appel JB
    Eur J Pharmacol; 1986 Dec; 132(1):87-91. PubMed ID: 2949989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discriminative stimulus properties of the dopamine D3 antagonist PNU-99194A.
    Franklin SR; Baker LE; Svensson KA
    Psychopharmacology (Berl); 1998 Jul; 138(1):40-6. PubMed ID: 9694525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that the stimulus properties of apomorphine are mediated by both D1 and D2 receptor activation.
    Schechter MD; Greer NL
    Life Sci; 1987 Jun; 40(25):2461-71. PubMed ID: 2953944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inverse agonist properties of the FG 7142 discriminative stimulus.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1991 Jan; 38(1):99-104. PubMed ID: 1850137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BMY 7378 and NAN-190.
    Barrett JE; Gleeson S
    Eur J Pharmacol; 1992 Jul; 217(2-3):163-71. PubMed ID: 1425937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle.
    Prus AJ; Philibin SD; Pehrson AL; Porter JH
    Behav Pharmacol; 2006 Mar; 17(2):185-94. PubMed ID: 16495726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differentiation of 5-HT1A receptor ligands by drug discrimination.
    Wolff MC; Leander JD
    Eur J Pharmacol; 1997 Aug; 333(2-3):113-22. PubMed ID: 9314023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline.
    Woolverton WL; Kamien JB; Goldberg LI
    Pharmacol Biochem Behav; 1985 Apr; 22(4):577-81. PubMed ID: 3873077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Buspirone fails to affect the discriminative stimulus effects of cocaine.
    Rapoza D
    Pharmacol Biochem Behav; 1993 May; 45(1):179-83. PubMed ID: 8516356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation.
    Goudie AJ; Atkinson J; West CR
    Neuropharmacology; 1986 Jan; 25(1):85-94. PubMed ID: 2869439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the effects of typical and atypical anxiolytics on learning in monkeys and rats.
    Winsauer PJ; Bixler MA; Mele PC
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1111-27. PubMed ID: 8786542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
    Millan MJ; Iob L; Péglion JL; Dekeyne A
    Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blockade of apomorphine's discriminative stimulus properties: relation to neuroleptic activity in neuropharmacological and biochemical assays.
    Colpaert FC; Leysen JE; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1976 Dec; 5(6):671-9. PubMed ID: 1035804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of SCH-23390 and raclopride on cocaine discrimination in male and female Wistar rats.
    Anderson KG; van Haaren F
    Pharmacol Biochem Behav; 2000 Apr; 65(4):671-5. PubMed ID: 10764921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists.
    Callahan PM; Cunningham KA
    Neuropharmacology; 1997 Mar; 36(3):373-81. PubMed ID: 9175616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discriminative stimulus properties of diazepam and the novel anxiolytic agent 1-amino-5-bromouracil in rats.
    Imaizumi M; Miyazaki S; Machida H
    Arzneimittelforschung; 1994 Oct; 44(10):1105-7. PubMed ID: 7818580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
    Glennon RA
    Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.
    Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2000 Feb; 148(2):209-16. PubMed ID: 10663437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cocaine cue in rats as it relates to subjective drug effects: a preliminary report.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Eur J Pharmacol; 1976 Nov; 40(1):195-9. PubMed ID: 991926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.